Track topics on Twitter Track topics that are important to you
Erratum Murthy et al., "The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats" Diabetes & Vascular Disease Research 2010 7(2):138-144. In the above paper the Acknowledgments section was printed incorrectly. It should have read: Acknowledgements Supported by Lilly - Amylin and, in part, by NIH grants HL62000, and HL77421. Dr Fonseca is also supported by NIH clinical trials (ACCORD and TINSAL-T2D) and by a grant from the American Diabetes Association and the Tullis Tulane Alumni Chair in Diabetes.
This article was published in the following journal.
[This corrects the article on p. 243 in vol. 47, PMID: 26069359.].
[This corrects the article on p. 851 in vol. 7.].
This erratum amends the wrongly cited NSF grant number in acknowledgment section in our publication.
Work consisting of an acknowledgment of an error, issued by a publisher, editor, or author. It customarily cites the source where the error occurred, giving complete bibliographic data for retrieval. In the case of books and monographs, author, title, imprint, paging, and other helpful references will be given; in the case of journal articles, the author, title, paging, and journal reference will be shown. An erratum notice is variously cited as Errata or Corrigenda.
Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells. In vertebrates, it is composed of blo...